"You can't save your way to success in this business."

Marina Biotech Inc.'s CEO Michael French on the tough financial choices small biotechs must make

"Life sciences events are not binary; it's not a two-sided coin."

Todd Wyche, founder of Brinson Patrick Securities, on the need for life sciences firms to shift their financing strategies

"Who the Gila saw this coming?"

J.P. Morgan analyst Cory Kasimov in a research note on Bydureon's surprise miss in showing non-inferiority to Victoza